Phase 3 Randomized Study Comparing X-396 to Crizotinib in Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC) Patients (X396-CLI-301)
Supported projects > Other Supported Projects · 2017
Authors: Tuncay GÖKSEL
2017-2021, Other Supported Projects, R & D Project, Continues